Legal
Key facts
Hagens Berman is conducting an investigation into Embecta Corp. (NASDAQ: EMBC) regarding alleged violations of federal…
Key facts
A class action lawsuit was recently filed in the U.S. District Court for the District of…
Key facts
The complaint alleges Embecta misrepresented the commercial stability of its insulin pen needle business
Atlas Watchline
Hagens Berman says it is investigating Embecta Corp. after a class action accused the company of…